中國光大水務(01857.HK)擬就唐冶新區污水處理廠項目成立合營公司
格隆匯12月17日丨中國光大水務(01857.HK)公佈,有關公司與濟南四建及濟南市歷城區東部新區發展服務中心獲濟南市歷城區人民政府授權就唐冶新區污水處理廠政府和社會資本合作項目成立合營公司而訂立項目合同的公告。
合營公司光水(濟南唐冶)水務有限公司已根據項目合同的條款於中華人民共和國設立,註冊資本為人民幣104,291,600元。合營公司的設立導致合營公司成為公司間接擁有99.9%權益的附屬公司。合營公司的主要業務活動包括(a)污水處理、中水回用、污泥處置及相關技術諮詢及技術服務;(b)銷售污水處理的設備;以及(c)污水處理廠的建設及運營。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.